• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性药物成分/聚合物固体分散体的热力学相行为

Thermodynamic phase behavior of API/polymer solid dispersions.

作者信息

Prudic Anke, Ji Yuanhui, Sadowski Gabriele

机构信息

Department of Biochemical and Chemical Engineering, Laboratory of Thermodynamics, TU Dortmund , Emil-Figge-Str. 70, D-44227 Dortmund, Germany.

出版信息

Mol Pharm. 2014 Jul 7;11(7):2294-304. doi: 10.1021/mp400729x. Epub 2014 May 28.

DOI:10.1021/mp400729x
PMID:24870944
Abstract

To improve the bioavailability of poorly soluble active pharmaceutical ingredients (APIs), these materials are often integrated into a polymer matrix that acts as a carrier. The resulting mixture is called a solid dispersion. In this work, the phase behaviors of solid dispersions were investigated as a function of the API as well as of the type and molecular weight of the carrier polymer. Specifically, the solubility of artemisinin and indomethacin was measured in different poly(ethylene glycol)s (PEG 400, PEG 6000, and PEG 35000). The measured solubility data and the solubility of sulfonamides in poly(vinylpyrrolidone) (PVP) K10 and PEG 35000 were modeled using the perturbed-chain statistical associating fluid theory (PC-SAFT). The results show that PC-SAFT predictions are in a good accordance with the experimental data, and PC-SAFT can be used to predict the whole phase diagram of an API/polymer solid dispersion as a function of the kind of API and polymer and of the polymer's molecular weight. This remarkably simplifies the screening process for suitable API/polymer combinations.

摘要

为提高难溶性活性药物成分(API)的生物利用度,这些物质通常会被整合到作为载体的聚合物基质中。所得混合物称为固体分散体。在这项工作中,研究了固体分散体的相行为与API以及载体聚合物的类型和分子量之间的关系。具体而言,测定了青蒿素和吲哚美辛在不同聚乙二醇(PEG 400、PEG 6000和PEG 35000)中的溶解度。使用扰动链统计缔合流体理论(PC-SAFT)对测得的溶解度数据以及磺胺类药物在聚乙烯吡咯烷酮(PVP)K10和PEG 35000中的溶解度进行了建模。结果表明,PC-SAFT预测与实验数据吻合良好,并且PC-SAFT可用于预测API/聚合物固体分散体的整个相图,该相图是API和聚合物种类以及聚合物分子量的函数。这显著简化了合适的API/聚合物组合的筛选过程。

相似文献

1
Thermodynamic phase behavior of API/polymer solid dispersions.活性药物成分/聚合物固体分散体的热力学相行为
Mol Pharm. 2014 Jul 7;11(7):2294-304. doi: 10.1021/mp400729x. Epub 2014 May 28.
2
Influence of copolymer composition on the phase behavior of solid dispersions.共聚物组成对固体分散体相行为的影响。
Mol Pharm. 2014 Nov 3;11(11):4189-98. doi: 10.1021/mp500412d. Epub 2014 Oct 21.
3
Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.聚乙烯吡咯烷酮和聚乙烯吡咯烷酮-醋酸乙烯酯无定形固体分散体的长期物理稳定性
Mol Pharm. 2017 Jan 3;14(1):157-171. doi: 10.1021/acs.molpharmaceut.6b00763. Epub 2016 Dec 7.
4
Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.低分子量辅料对 PVPVA64 无定形固体分散体相行为的影响。
Pharm Res. 2018 Jan 5;35(1):25. doi: 10.1007/s11095-017-2316-y.
5
Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?纯从 PC-SAFT 预测活度系数能否有助于药物-聚合物相容性筛选?
Mol Pharm. 2023 Aug 7;20(8):3960-3974. doi: 10.1021/acs.molpharmaceut.3c00124. Epub 2023 Jun 29.
6
Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.聚合物类型和相对湿度对无定形固体分散体长期物理稳定性的影响。
Mol Pharm. 2017 Dec 4;14(12):4374-4386. doi: 10.1021/acs.molpharmaceut.7b00492. Epub 2017 Nov 7.
7
Physical stability of API/polymer-blend amorphous solid dispersions.原料药/聚合物共混无定形固体分散体的物理稳定性。
Eur J Pharm Biopharm. 2018 Mar;124:147-157. doi: 10.1016/j.ejpb.2017.12.002. Epub 2017 Dec 18.
8
Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.无定形固体分散体中相分离/结晶和吸水的相互影响。
Mol Pharm. 2018 Feb 5;15(2):669-678. doi: 10.1021/acs.molpharmaceut.7b01076. Epub 2018 Jan 19.
9
Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.药物活性成分在聚合物基质中的微尺度溶解度评估和预测模型。
Eur J Pharm Biopharm. 2019 Aug;141:111-120. doi: 10.1016/j.ejpb.2019.05.012. Epub 2019 May 14.
10
Phase behavior of pharmaceutically relevant polymer/solvent mixtures.药用相关聚合物/溶剂混合物的相行为。
Int J Pharm. 2020 Mar 15;577:119065. doi: 10.1016/j.ijpharm.2020.119065. Epub 2020 Jan 24.

引用本文的文献

1
Advancing amorphous solid dispersions through empirical and hybrid modeling of drug-polymer solubility and miscibility: A case study using Ibuprofen.通过药物-聚合物溶解度和混溶性的经验模型与混合模型推进无定形固体分散体:以布洛芬为例的案例研究
Int J Pharm X. 2025 Aug 9;10:100373. doi: 10.1016/j.ijpx.2025.100373. eCollection 2025 Dec.
2
Predicting the Release Mechanism of Amorphous Solid Dispersions: A Combination of Thermodynamic Modeling and In Silico Molecular Simulation.预测无定形固体分散体的释放机制:热力学建模与计算机分子模拟相结合
Pharmaceutics. 2024 Oct 2;16(10):1292. doi: 10.3390/pharmaceutics16101292.
3
COSMOPharm: Drug-Polymer Compatibility of Pharmaceutical Amorphous Solid Dispersions from COSMO-SAC.
COSMOPharm:COSMO-SAC 法评估药物聚合物的药用无定形固体分散体的相容性。
Mol Pharm. 2024 Sep 2;21(9):4395-4415. doi: 10.1021/acs.molpharmaceut.4c00342. Epub 2024 Jul 30.
4
Composition Dependency of the Flory-Huggins Interaction Parameter in Drug-Polymer Phase Behavior.药物-聚合物相行为中弗洛里-哈金斯相互作用参数的组成依赖性
Pharmaceutics. 2023 Nov 21;15(12):2650. doi: 10.3390/pharmaceutics15122650.
5
Polymorphism in Solid Dispersions.固体分散体中的多晶型现象。
Cryst Growth Des. 2020 Feb 5;20(2):713-722. doi: 10.1021/acs.cgd.9b01138. Epub 2019 Dec 17.
6
Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose.定制的动脉粥样硬化斑块不稳定化——用羟丙基纤维素平衡保质期稳定性和溶解性能。
Int J Pharm X. 2023 Jun 7;5:100187. doi: 10.1016/j.ijpx.2023.100187. eCollection 2023 Dec.
7
Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?纯从 PC-SAFT 预测活度系数能否有助于药物-聚合物相容性筛选?
Mol Pharm. 2023 Aug 7;20(8):3960-3974. doi: 10.1021/acs.molpharmaceut.3c00124. Epub 2023 Jun 29.
8
Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.非晶态固体分散体 - 水界面层的热力学建模及其对释放机制的影响。
Pharmaceutics. 2023 May 19;15(5):1539. doi: 10.3390/pharmaceutics15051539.
9
Anomalous Water-Sorption Kinetics in ASDs.自组装药物递送系统中异常的水吸附动力学
Pharmaceutics. 2022 Sep 7;14(9):1897. doi: 10.3390/pharmaceutics14091897.
10
Predicting the Water Sorption in ASDs.预测自组装药物递送系统中的水吸附作用。
Pharmaceutics. 2022 May 31;14(6):1181. doi: 10.3390/pharmaceutics14061181.